Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries [0.03%]
联合风疹和人乳头瘤病毒疫苗的安全性与免疫原性的临床前研究：提高发展中国家疫苗接种率的方法
Asmaa Gohar,Nourtan F Abdeltawab,Nahla Shehata et al.
Asmaa Gohar et al.
Rubella vaccine was not part of national immunization programs (NIP) in several countries in the Middle East and North Africa (MENA), South-East Asia (SEA), and South Africa regions until the year 2000. Therefore, immunization coverage of f...
Karen Canfell
Karen Canfell
Two very effective prevention strategies for cervical cancer exist - vaccination against the human papillomavirus (HPV) and cervical screening with primary HPV testing followed by treatment of precancerous lesions. In 2018, the World Health...
Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents [0.03%]
威斯康星州青少年人乳头瘤病毒疫苗态度和接种的社会人口学及临床因素分析
Kayla E Hanson,Huong Q McLean,Edward A Belongia et al.
Kayla E Hanson et al.
Few studies have assessed adolescent human papillomavirus (HPV) vaccine attitudes and whether they are associated with vaccination uptake. This study characterized HPV vaccine attitudes among male and female adolescents, identified factors ...
Japanese physicians' attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines [0.03%]
日本医生的人乳头瘤病毒疫苗态度及其与其他青少年疫苗的接种意愿比较
Tomohiro Katsuta,Charlotte A Moser,Paul A Offit et al.
Tomohiro Katsuta et al.
Introduction: Japan has experienced extremely low human papillomavirus vaccine (HPVV) coverage following the suspension of proactive governmental recommendations in 2013. Several studies have reported that recommendations...
Mark Schiffman,Silvia de Sanjose
Mark Schiffman
In cervical cancer screening, HPV testing is best at reassuring women when they are negative, but proper management of HPV positives is still evolving. Most HPV infections are benign, and over-reacting clinically to HPV positivity can cause...
Silvia de Sanjose,Francesca Holme
Silvia de Sanjose
Effective screening for pre-cancerous lesions of the cervix is the only protective intervention that can be offered to women that have not had the opportunity to be vaccinated. Elimination goals are being developed so that by 2030, 70% of w...
HPV16 variant analysis in primary and recurrent CIN2/3 lesions demonstrates presence of the same consensus variant [0.03%]
人乳头瘤病毒16型一致株在宫颈CIN2/3原发和复发病变中的存在
Pascal van der Weele,Audrey J King,Chris J L M Meijer et al.
Pascal van der Weele et al.
Introduction: Recurrent cervical intraepithelial lesions (rCIN2/3) after treatment of CIN2/3 occur in 5-15% of cases. rCIN2/3 can result from incomplete resection of CIN2/3, where the same HPV type and variant remains pre...
The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection [0.03%]
人乳头瘤病毒感染的和未感染的南非育龄妇女的宫颈微生物群结构特征研究
Harris Onywera,Anna-Lise Williamson,Zizipho Z A Mbulawa et al.
Harris Onywera et al.
In this study we examined potential associations of HPV infection with the cervical microbiota. Cervical samples were collected from 87 HIV-seronegative reproductive-age Black South African women. Microbiota were characterized by Illumina s...
Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry [0.03%]
影响人乳头瘤病毒感染的细胞外事件：上皮损伤至参与病毒进入的信号转导
Michelle A Ozbun
Michelle A Ozbun
Human papillomaviruses (HPVs), like all PVs, predominantly cause benign tumors, or warts, in stratifying squamous epithelial tissues. Virions are released from apical surfaces of the skin and mucosa and, to initiate a new infection, must ut...
Opportunities to improve immune-based prevention of HPV-associated cancers [0.03%]
提高针对HPV相关癌症的免疫预防措施的机会
Peter L Stern,Richard Bs Roden
Peter L Stern
Immunization of adolescent girls with VLP vaccines, made of L1 proteins from the most medically significant high risk HPV types, is a major strategy for prevention of cervical cancer plus other HPV-associated cancers. Maximal population imp...